These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32186022)
1. Three Tiaobu Feishen therapies protect human alveolar epithelial cells against cigarette smoking and tumor necrosis factor--induced inflammation by nuclear factor-kappa B pathway. Chen Y; Wu Y; Li J; Feng S; Hao L; Liu X; Zheng W; Dong H; Qin Y; Yin S; Zhao P; Chen Y; Wu Y; Li J; Feng S; Hao L; Liu X; Zheng W; Dong H; Qin Y; Yin S; Zhao P J Tradit Chin Med; 2019 Feb; 39(1):45-49. PubMed ID: 32186022 [TBL] [Abstract][Full Text] [Related]
2. Three Tiaobu Feishen formulae reduces cigarette smoke-induced inflammation in human airway epithelial cells. Dong H; Liu X; Zheng W; Feng S; Li J; Qin Y; Wu Y; Chen Y; Yin S; Zhao P J Tradit Chin Med; 2020 Jun; 40(3):386-392. PubMed ID: 32506851 [TBL] [Abstract][Full Text] [Related]
3. Tiaobu Feishen therapy inhibits inflammation induced by cigarette smoke extracts in a human monocyte/macrophage cell line. Qin YQ; Chen YL; Zhao P; Feng SX; Wu YS; Liu XF; Dong HR; Zheng WC; Mao XN; Li JS J Tradit Chin Med; 2021 Jun; 41(3):360-366. PubMed ID: 34114392 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease. Li JS; Li Y; Li SY; Wang YY; Deng L; Tian YG; Jiang SL; Wang Y Zhong Xi Yi Jie He Xue Bao; 2012 Sep; 10(9):1039-48. PubMed ID: 22979936 [TBL] [Abstract][Full Text] [Related]
5. Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF- Jin F; Zhang L; Chen K; Miao Y; Liu Y; Tian Y; Li J Biomed Res Int; 2022; 2022():3360771. PubMed ID: 35586807 [TBL] [Abstract][Full Text] [Related]
6. Andrographolide antagonizes cigarette smoke extract-induced inflammatory response and oxidative stress in human alveolar epithelial A549 cells through induction of microRNA-218. Li YJ; Yu CH; Li JB; Wu XY Exp Lung Res; 2013 Dec; 39(10):463-71. PubMed ID: 24298938 [TBL] [Abstract][Full Text] [Related]
7. Carbocisteine attenuates TNF-α-induced inflammation in human alveolar epithelial cells in vitro through suppressing NF-κB and ERK1/2 MAPK signaling pathways. Wang W; Guan WJ; Huang RQ; Xie YQ; Zheng JP; Zhu SX; Chen M; Zhong NS Acta Pharmacol Sin; 2016 May; 37(5):629-36. PubMed ID: 26997568 [TBL] [Abstract][Full Text] [Related]
8. Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease. Li Y; Li JS; Li WW; Li SY; Tian YG; Lu XF; Jiang SL; Wang Y BMC Complement Altern Med; 2014 Apr; 14():140. PubMed ID: 24766819 [TBL] [Abstract][Full Text] [Related]
9. A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38. Li J; Xie Y; Zhao P; Qin Y; Oliver BG; Tian Y; Li S; Wang M; Liu X Phytomedicine; 2021 Mar; 83():153475. PubMed ID: 33545548 [TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-κB/MAPKs signaling pathways. Zhao Z; Tong Y; Kang Y; Qiu Z; Li Q; Xu C; Wu G; Jia W; Wang P Mol Immunol; 2023 Nov; 163():224-234. PubMed ID: 37864932 [TBL] [Abstract][Full Text] [Related]
11. [ Xu C; Li C; Wang S Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):507-515. PubMed ID: 37202185 [TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappaB regulates the transcription of NADPH oxidase 1 in human alveolar epithelial cells. Wu W; Li L; Su X; Zhu Z; Lin X; Zhang J; Zhuang Z; Cai H; Huang W BMC Pulm Med; 2021 Mar; 21(1):98. PubMed ID: 33757467 [TBL] [Abstract][Full Text] [Related]
14. Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling. Li J; Ma J; Tian Y; Zhao P; Liu X; Dong H; Zheng W; Feng S; Zhang L; Wu M; Zhu L; Liu S; Zhao D J Ethnopharmacol; 2020 Jul; 257():112796. PubMed ID: 32344236 [TBL] [Abstract][Full Text] [Related]
15. Ginseng Saponin Rb1 Attenuates Cigarette Smoke Exposure-Induced Inflammation, Apoptosis and Oxidative Stress via Activating Nrf2 and Inhibiting NF-κB Signaling Pathways. Li Z; Li L; Lv X; Hu Y; Cui K Int J Chron Obstruct Pulmon Dis; 2023; 18():1883-1897. PubMed ID: 37662486 [TBL] [Abstract][Full Text] [Related]
16. Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD. Zhao P; Li J; Li Y; Tian Y; Wang Y; Zheng C Int J Chron Obstruct Pulmon Dis; 2015; 10():2633-56. PubMed ID: 26674991 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of inflammation-induced injury and cell migration by coelonin and militarine in PM Cheng W; Lu J; Wang B; Sun L; Zhu B; Zhou F; Ding Z Eur J Pharmacol; 2021 Apr; 896():173931. PubMed ID: 33549578 [TBL] [Abstract][Full Text] [Related]
18. CD200Fc attenuates inflammatory responses and maintains barrier function by suppressing NF-κB pathway in cigarette smoke extract induced endothelial cells. Xu J; Lu L; Lu J; Xia J; Lu H; Yang L; Xia W; Shen S Biomed Pharmacother; 2016 Dec; 84():714-721. PubMed ID: 27710895 [TBL] [Abstract][Full Text] [Related]
19. Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway. Li MY; Qin YQ; Tian YG; Li KC; Oliver BG; Liu XF; Zhao P; Li JS BMC Pulm Med; 2022 Nov; 22(1):434. PubMed ID: 36414945 [TBL] [Abstract][Full Text] [Related]
20. Traditional herbal formula Jakyakgamcho-tang (Paeonia lactiflora and Glycyrrhiza uralensis) impairs inflammatory chemokine production by inhibiting activation of STAT1 and NF-κB in HaCaT cells. Jeong SJ; Lim HS; Seo CS; Kim JH; Jin SE; Yoo SR; Shin HK Phytomedicine; 2015 Feb; 22(2):326-32. PubMed ID: 25765840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]